Sorato et al. Clin Med Rev Case Rep 2020, 7:307 Volume 7 | Issue 5 DOI: 10.23937/2378-3656/1410307 Accepted: May 02, 2020: Published: May 04, 2020 Citaton: Sorato MM, Davari M, AbdollahiAsl A (2020) Descriptve Evaluaton of Natonal and Interna- tonal Hypertension Treatment Guidelines: The Guideline Quality and Comprehensiveness to provide Care to Adult with Hypertension. Clin Med Rev Case Rep 7:307. doi.org/10.23937/2378-3656/1410307 Copyright: © 2020 Sorato MM, et al. This is an open-access artcle distributed under the terms of the Creatve Commons Atributon License, which permits unrestricted use, distributon, and reproducton in any medium, provided the original author and source are credited. ISSN: 2378-3656 Open Access Clinical Medical Reviews and Case Reports Sorato et al. Clin Med Rev Case Rep 2020, 7:307 • Page 1 of 14 • Descriptve Evaluaton of Natonal and Internatonal Hyperten- sion Treatment Guidelines: The Guideline Quality and Compre- hensiveness to provide Care to Adult with Hypertension Mende Mensa Sorato * , Majid Davari and Akbar AbdollahiAsl Department of Pharmacoeconomics and pharmaceutcal Administraton, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran Abstract Background: Hypertension (Blood pressure ≥ 140/90 mmHg) is the modifable risk factor responsible for a host of complications. Evidence based guidelines are important for prevention and control of hypertension. However, there is variation and inconsistencies among published guidelines concerning, diagnosis and treatment approach. Therefore, this review was conducted with intension to evaluatequality and comprehensiveness of published national adult hyper- tension treatment guideline, diagnosis and treatment ap- proach in comparison with other national and international guidelines. Methods: We selected national guidelines of fve countries (USA of America, Canada, Europe, Australia and Ethiopia) and one international guideline.We used clinical guideline appraisal tool to evaluate the quality of guidelines, and com- prehensiveness of the guidelines was evaluated by using a tool developed reach team. Evidence synthesis: We qualitatively synthesized the ev- idence by reviewing quality and comprehensiveness ofse- lected guidelines. Results: National adult hypertension treatment guideline of Ethiopia addressed only 22 (64.7%) of quality appraisal tool components. The guideline is least comprehensive 15 (51.7%). Major problems the guideline were; lack of diag- nostic approach for masked, white-coat and resistant hy- pertension; failure to address child hood risk factors and secondary cases of hypertension. Similarly, management of hypertension in patients undergoing surgery, specifc pa- tient groups, access to medicine and social determinants of health are not addressed. Conclusion: Quality and comprehensiveness of National hypertension guideline of Ethiopia is poor. Therefore, we recommend the guideline development committee and oth- er relevant stakeholders to: update the blood pressure tar- gets for elderly population, determine when to initiate and intensify antihypertensive drug therapy; address social de- terminants and socioeconomic status of population includ- ing maternal nutrition and Access of medicines. Keywords Hypertension treatment guidelines, Management of hyper- tension in adults, Evidence based guideline, Ethiopia Abbreviations ABPM: Ambulatory Blood Pressure Monitoring; ACC/AHA: American College of Cardiology/American Heart Associa- tion; AGREE: Appraisal of Guidelines for Research &Eval- uation; ASCVD: Atherosclerotic Cardiovascular Diseases; CHD: Coronary Heart Disease; CKD: Chronic Kidney Dis- ease; CVD: Cardiovascular Diseases; ESC/ESH: European Society of Cardiology/European Society of Hypertension; ESRD: End Stage Renal Disease; FGR: Fetal Growth Re- striction; HBPM: Home Blood Pressure Monitoring; HF: Heart Failure; JNC: Joint National Committee guideline for management of raised blood pressure in adults; LDL-C: Low Density Lipoprotein- Cholesterol; MI: Myocardial Infarction; NCDs: Non-Communicable Diseases; PAD: Peripheral Ar- terial Disease; SPC: Single Pill Combination; SPRINT:Sys- tolic Blood Pressure Intervention Trial; TIA: Transient Isch- emic Attack *Corresponding author: Mende Mensa Sorato, B.Pharm, MSc. PhD scholar, Department of Pharmacoeconomics and pharmaceutcal Administraton, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran, Tel: +98-9056309138 Review ARticle Check for updates Background Hypertension (Blood pressure ≥ 140/90 mmHg) is the modifable risk factor responsible for host of compli- catons. Startng at a blood pressure of 115/75 mmHg,